Common Side Effects of Icosapent Ethyl
Icosapent ethyl, sold as Vascepa, commonly causes musculoskeletal pain (like joint or muscle aches), peripheral edema (swelling in arms or legs), constipation, gout, and atrial fibrillation. These affect 3-5% of patients in clinical trials, higher than placebo.[1][2]
How Often Do They Occur?
In the pivotal REDUCE-IT trial, gout occurred in 3.9% of patients on icosapent ethyl versus 2.9% on placebo. Musculoskeletal issues hit 4.5% versus 3.8%, and atrial fibrillation rose to 5.3% from 3.9%. Most are mild and resolve without stopping treatment.[2][3]
Serious Risks Patients Worry About
Bleeding events, like epistaxis (nosebleeds) or hematuria, occur at low rates (2-3%) but warrant monitoring, especially with anticoagulants. Atrial fibrillation risk increases slightly, prompting ECG checks in some cases. No increased liver enzyme elevations or myopathy seen.[1][2]
Differences from Other Fish Oils
Unlike mixed EPA/DHA fish oils (e.g., Lovaza), icosapent ethyl's pure EPA form shows fewer GI issues like eructation (fishy burps) or dyspepsia. Still, it shares gout risk from hyperuricemia.[3]
What to Do If Side Effects Hit
Most resolve on their own or with dose adjustments. Report bleeding, severe swelling, or irregular heartbeat to a doctor immediately. Taking with food may ease constipation.[1]
[1]: FDA Vascepa Label
[2]: REDUCE-IT Trial (NEJM)
[3]: Drugs.com - Icosapent Ethyl Side Effects